As noted in the OneMarket Demerger Booklet released in April 2018, Mr. Kingsborough has experienced health issues which have been closely monitored by the Board. Over the course of 2018, Mr. Kingsborough has been undergoing treatment for his condition, to which he has responded well. However, Mr. Kingsborough has recently advised the Board that he is experiencing complications as a result of the treatment. Those complications are impacting Mr. Kingsborough's ability to perform his duties as CEO. As a result, Mr. Kingsborough has advised the Board that he will step down from the CEO role for health reasons with effect from a date to be agreed in the first quarter of 2019. In the period prior to his departure, Mr. Kingsborough will remain as CEO but is expected to take leave of absence as required in order to receive further treatment. Mr. Kingsborough will continue to work closely with the Chairman and the senior management team. It is expected that Mr. Kingsborough will remain on the Board of OneMarket Limited after stepping down as the CEO.